Vaka 20
Özet
Bu vaka, sistemik malignite öyküsü bulunan bir hastada gelişen beyin metastazını tanımlamaktadır. MRG’de çevresel kontrastlanan, geniş vazojenik ödemle çevrili kitle görünümü tipiktir. Difüzyon ve perfüzyon bulguları metastatik özellikleri destekler. Tedavi; cerrahi, radyocerrahi ve sistemik tedavilerin kombinasyonunu içerir.
Referanslar
Leal T, Julie E, Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment, Curr Cancer Ther Rev. 2011 ; 7; 319–327.
Foo C.T., Burrel.L.M., An unusual presentation of carcinomatous meningitis Oxford Medical Case Reports, 2016;8, 159–162.
Nayar G, Ejikeme T, Chongsathidkiet P, et al. Leptomeningeal disease: Current diagnostic and therapeutic strategies. Oncotarget 2017, 8, 73312–73328.
Gleissner B, Chamberlain M.C. Neoplastic meningitis. Lancet Neurol. 2006, 5, 443–452.
Batool A, Kasi A. Leptomeningeal Carcinomatosis. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023.
Hazem IA, Tala M, Fadi S, et al. Management of leptomeningeal metastasis in breast cancer. Clinical Neurology and Neurosurgery.2018 172 (151-159). Doi:10.1016/j.clineuro.2018.07.001
Clarke J, Perez H, Jacks L,et al. Leptomeningeal Metastases in the MRI Era. Neurology. 2010;74(18):1449-54. doi:10.1212/WNL.0b013e3181dc1a69.
Chang EL, Maor MH. Standard and novel radiotherapeutic approaches to neoplastic meningitis. Curr Oncol Rep. 2003;5(1):24–28. http://www.ncbi.nlm.nih.gov/pubmed/12493147.
Rudnicka H, Niwińska A, Murawska M. Breast cancer leptomeningeal metastasis - The role of multimodality treatment. J Neurooncol. 2007;84(1):57–62. 10.1007/s11060-007-9340-4.